Diabetes Mellitus and Risk of Incident Dementia in Apoe E4 Carriers: An Updated Meta-Analysis Publisher Pubmed



Rashtchian A¹ ; Etemadi MH² ; Asadi E¹ ; Binaei S³ ; Abbasi M⁴ ; Bayani M⁵ ; Izadi E⁶ ; Sadatmadani SF⁷ ; Naziri M⁸ ; Khoshravesh S⁹ ; Shirani M¹ ; Asadi Anar M¹ ; Deravi N¹
Source: BMC Neuroscience Published:2024

Abstract

Background and aim: Diabetes raises the risk of dementia, mortality, and cognitive decline in the elderly, potentially because of hereditary variables such as APOE. In this study, we aim to evaluate Diabetes mellitus and the risk of incident dementia in APOE e4 carriers. Method: We thoroughly searched PubMed (Medline), Scopus, and Google Scholar databases for related articles up to September 2023. The titles, abstracts, and full texts of articles were reviewed; data were extracted and analyzed. Result: This meta-analysis included nine cohorts and seven cross-sectional articles with a total of 42,390 population. The study found that APOE e4 carriers with type 2 diabetes (T2D) had a 48% higher risk of developing dementia compared to non-diabetic carriers (Hazard Ratio;1.48, 95%CI1.36–1.60). The frequency of dementia was 3 in 10 people (frequency: 0.3; 95%CI (0.15–0.48). No significant heterogeneity was observed. Egger’s test, which we performed, revealed no indication of publication bias among the included articles (p = 0.2). Conclusion: Overall, diabetes increases the risk of dementia, but further large-scale studies are still required to support the results of current research. © The Author(s) 2024.